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Summary
The Salvador-Warts-Hippo (Hippo) pathway is an evolution-
arily conserved regulator of organ growth and cell fate. It
performs these functions in epithelial and neural tissues of
both insects and mammals, as well as in mammalian organs
such as the liver and heart. Despite rapid advances in Hippo
pathway research, a definitive role for this pathway in he-
matopoiesis has remained enigmatic. The hematopoietic
compartments of Drosophila melanogaster and mammals
possess several conserved features [1, 2]. D. melanogaster
possess three types of hematopoietic cells that most closely
resemble mammalian myeloid cells: plasmatocytes (macro-
phage-like cells), crystal cells (involved in wound healing),
and lamellocytes (which encapsulate parasites). The pro-
teins that control differentiation of these cells also control
important blood lineage decisions in mammals [3–10].
Here, we define the Hippo pathway as a key mediator of he-
matopoiesis by showing that it controls differentiation and
proliferation of the two major types of D. melanogaster
blood cells, plasmatocytes and crystal cells. In animals lack-
ing the downstream Hippo pathway kinase Warts, lymph
gland cells overproliferated, differentiated prematurely,
and often adopted a mixed lineage fate. The Hippo pathway
regulated crystal cell numbers by both cell-autonomous
and non-cell-autonomous mechanisms. Yorkie and its part-
ner transcription factor Scalloped were found to regulate
transcription of the Runx family transcription factor Lo-
zenge, which is a key regulator of crystal cell fate. Further,
Yorkie or Scalloped hyperactivation induced ectopic crystal
cells in a non-cell-autonomous and Notch-pathway-depen-
dent fashion.
Results and Discussion
Hippo Pathway Components Are Expressed in
D. melanogaster Hematopoietic Cells
We adopted D. melanogaster as a system to investigate a
potential role for the Hippo pathway in hematopoiesis since
this pathway was first discovered and is best understood in
this organism. The best-described hematopoietic organ in
D. melanogaster is the larval lymph gland, which matures*Correspondence: kieran.harvey@petermac.orgduring larval development and ruptures during metamor-
phosis to give rise to circulating hemocytes in the pupa and
adult [1, 2]. The lymph gland is a paired multilobed structure:
the large primary lymph gland lobes contain differentiating
cells in the cortical zone, whereas themedullary zone contains
undifferentiated cells and the posterior signaling center (PSC)
acts as a hematopoietic niche that serves tomaintain themed-
ullary zone prohemocyte population [1, 2]. The secondary
lobes, which vary in number but usually consist of between
two and four paired lobes, contain undifferentiated hemocyte
progenitor cells.
Initially, we studied expression of Hippo pathway compo-
nents and found that the upstream pathway members Merlin
(Mer), Fat (Ft), and four-jointed (fj) were expressed throughout
the lymph gland, as was the key transcriptional coactivator
protein Yorkie (Yki; Figures S1A–S1E available online). Some
cells exhibited higher Yki expression (Ykihigh), suggesting
that Yki activity is nonuniform in lymph glands. Eighty-six
percent of Ykihigh cells were Hindsight positive (Hnt+), which
marks terminally differentiated crystal cells [11] (Figures
S1D0 0 and S1E0 0). Scalloped (Sd), the best-defined of Yki’s part-
ner transcription factors [12–16], was observed throughout the
lymph gland, was strongest in the primary lobe medullary
zone, and was expressed at low levels in 89% of crystal cells
(Figures S1F and S1G).
The Hippo Pathway Kinase Warts Regulates Blood Cell
Differentiation
To determine whether the Hippo pathway regulates hemato-
poietic development, we analyzed the number and location
of the two predominant differentiated cell types, plasmato-
cytes (P1+) and crystal cells (Hnt+), in lymph glands fromwarts
(wts) hypomorphs. Both plasmatocytes and crystal cells were
increased in number and were present throughout the medul-
lary zone of the primary lobe and the secondary lobes, where
normally only hemocyte progenitors reside, rather than being
restricted to the cortical zone of the primary lobe (Figures
1A–1D). To analyze this more closely, we assessed hemocyte
differentiation in wild-type and wts lymph glands throughout
development in carefully staged animals. Plasmatocytes and
crystal cells were absent from wild-type lymph glands at the
late second larval instar; however, strikingly, the majority of
wts mutant glands displayed strong expression of both Hnt
and P1 (Figures 1E–1H0). P1+, but not Hnt+, cells began to
appear in wild-type lymph glands in early third larval instar
development, but both cell populations were prevalent in wts
lymph glands (Figures 1I–1L0).
Differentiation into either a crystal cell or a plasmatocyte are
mutually exclusive fate decisions [17, 18]. To determine
whether this fate choice occurred normally in cells with aber-
rant Hippo pathway activity, we analyzed lymph glands from
15 wild-type and 15 wts animals, using P1 antibodies and
lozenge (lz)-Gal4-driven expression of UAS-GFP, which marks
crystal cells. All wild-type lymph glands displayed either lz+ or
P1+ cells but never lz+ P1+ (double-positive) cells (Figures 1M–
1M0 0). By contrast, all 15 wts lymph glands displayed multiple
cells that were positive for both lz-Gal4 and P1 (Figures 1N–
1N0 0). In three wts lymph glands, the majority of Lz+ cells also
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Figure 1. Warts Regulates Blood Cell Differentiation
(A–D) Controlw1118 (A and C) andwtsmutant lymph glands (B and D). Plasmatocytes were visualized by anti-P1 staining (grayscale in A and B) and merged
with direct interference contrast (DIC) images. wts mutant lymph glands exhibit P1 expression outside of its normal domain (yellow arrowheads). Crystal
(legend continued on next page)
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2675expressed P1, whereas 12 wts lymph glands displayed more
single lz+ cells than lz+ P1+ cells. Collectively, these results
indicate two key roles for the Hippo pathway in hemocyte dif-
ferentiation: (1) it maintains the progenitor state of hemocyte
progenitors during lymph gland development and (2) it pre-
vents hemocyte progenitors from differentiating inappropri-
ately to adopt a mixed crystal cell/plasmatoctye fate. The Hip-
po pathway regulates specific cell-fate choices, such as the
decision between inner cell mass and trophectoderm in the
early mouse embryo [19] and between R8 photoreceptor sub-
types in the D. melanogaster eye [20, 21]. In these scenarios,
the Hippo pathway regulates a binary fate choice, i.e., a deci-
sion between one cell type or another. Our data show that the
Hippo pathway does not regulate blood cell fate by stimulating
binary fate decisions, but rather prevents premature differenti-
ation of both major D. melanogaster blood lineages.
The Hippo Pathway Kinase Warts Regulates Blood Cell
Proliferation and Lymph Gland Size
We also noted that wts lymph glands were larger than in con-
trol animals. When quantified, wts lymph glands were 58%
larger in size than controls, showing that the Hippo pathway
also limits lymph gland growth, comparable to its growth-
repressive function in other larval tissues such as the imaginal
discs and brain (Figures 2A–2C and S2A–S2D) [22–24]. To
analyze this more closely, we assessed the proliferation pro-
files of age-matched wts mutant and wild-type lymph glands
throughout development. At each larval stage analyzed (late
second instar, early third instar, and mid third instar), wts
lymph glands were larger and possessed significantly more
cells in S phase than did control lymph glands (Figures 2D–
2L). Similar results were observed when mitotic cells were
analyzed using phospho-Histone H3 antibodies (Figures 2M–
2O), indicating that Wts normally limits lymph gland hemocyte
proliferation. The fact that wts lymph glands were larger and
more proliferative cannot account for the observed premature
differentiation, as excess proliferation induced by loss of other
growth suppressors in the lymph gland such as tuberous scle-
rosis complex 2 does not cause premature differentiation [25].
The Key Hippo Pathway Transcriptional Regulator Yorkie
Influences Crystal Cell Numbers
Yki is the key effector of the Hippo pathway and is a direct sub-
strate of theWts kinase [26]. To explore a role for Yki in hemato-
poiesis, we employed a null allele, ykiB5. ykimutant animals are
lethal soon after embryogenesis [26]. Therefore, we measured
the ratio of crystal cells per lymph gland cell (assessed by
DAPI intensity) in third-instar larval control animalsorykihemizy-
gotes. As shown in Figures 3A–3C, yki hemizygotes displayed a
significant reduction in crystal cells compared to wild-type ani-
mals, suggesting that full Yki activity is required fordevelopment
of the complete complement of crystal cells.cells were visualized by anti-Hnt staining (grayscale in C and D). Primary and se
possessed significantly more crystal cells, as well as precocious differentiatio
(E–L0) Late-second-instar controlw1118 (E andG) andwtsmutant (F and H) lymph
lymph glands. Plasmatocyteswere visualized by anti-P1 staining (grayscale in E
H, K, and L), and these were merged with DIC images in (E0), (F0), (G0), (H0), (I0),
plasmatocytes and crystal cells at late-second-instar larval stages, while cont
(M–N0 0) Controlw1118 (M–M0 0) andwtsmutant (N–N0 0) primary lymph glands. Crys
and N) and plasmatocytes were visualized by anti-P1 staining (grayscale in M0
rowheads in M–M0 0), whereas a significant number of crystal cells also expres
protein expression images are merged in (M0 0) and (N0 0).
Scale bars, 20 mm. See also Figure S1.To determine whether the Hippo pathway regulates crystal
cells in a cell-autonomous fashion, we depleted Wts by RNAi
or overexpressed hyperactive versions of Yki (Yki3SA [27])
or Sd (SdGA [15]) under the control of the crystal-cell-specific
lz-Gal4 driver. In each case, we observed a significant increase
in crystal cells compared to controls (Figures 3D–3E0 0 0 and
Figures S2E–S2H). The increase in crystal cells upon Wts
depletion was dependent on Yki, as when both proteins were
knocked down, the increase in crystal cells was significantly
suppressed (Figures 3F–3I). Yki hyperactivation induced
ectopic crystal cells in a cell-autonomous manner, as lz-driven
GFP completely overlapped with Hnt (Figures 3D0 0 0, 3E0 0 0, and
S2E0 0 0). To determine whether Sd reduction displayed a similar
phenotype to yki hemizygosity, we depleted Sd by RNAi in
developing crystal cells using lz-Gal4. Unexpectedly, we
observed a 2-fold increase in crystal cells (Figures S2I, S2J,
and S2L). This observation was reminiscent of Yki and Sd’s
role in posterior follicle cell fate in the D. melanogaster ovary.
At stages 7–9, both loss-of-function or gain-of-function Sd in-
duces the same phenotype, i.e., increased Cut+ cells [28],
because Sd functions with Yki to induce Cut expression in
these cells but also acts as a default repressor of Cut when
Yki activity is low. However, depletion of the Sd corepressor
Tgi using lz-Gal4 by RNAi did not affect crystal cell number,
suggesting that it is not an important regulator of crystal cell
number or fate (Figures S2K and S2L). Collectively, these
data suggest that the Hippo pathway regulates proliferation
and/or terminal differentiation of Lz+ progenitor cells, which
differentiate into crystal cells.
The Hippo Pathway Regulates Expression of the Key
Crystal Cell Fate Determinant, Lozenge
The above data show that total crystal cell numbers in larval
lymph glands are sensitive to modulation of Hippo pathway
activity during crystal cell maturation. Therefore, we investi-
gated functional links between Lz and the Hippo pathway
further. The human homologs of Yki and Lz (YAP and acute
myeloid leukemia 3 [AML3], also known as polyomavirus
enhancer binding protein [PEBP2a]) form a physical complex,
and YAP activates AML3 in transcription assays [29]. There-
fore, we tested whether Yki and Lz formed a physical interac-
tion in S2 cells, but we failed to detect such an association
(Figure S3A).
Next, given thatwts loss led to premature induction of crystal
cells, aswell as ectopic crystal cells in lymph gland regions that
normally only harbor progenitor cells, we considered the pos-
sibility that Yki and Sd regulate Lz expression. To test this,
we induced small Yki clones in lymph glands using the Actin-
Gal4 flip-out technique. Normally, Lz is expressed in crystal
cells of the cortical zone of the primary lymph gland, as well
as in the differentiating photoreceptor cells of the third-instar
larval eye disc [4, 30]. Strikingly, in yki-overexpressing clones,condary lobes are labeled 1 and 2, respectively.wtsmutant lymph glands
n of secondary gland hemocytes into crystal cells (yellow arrowheads in D).
glands and early-third-instar controlw1118 (I and K) andwtsmutant (J and L)
, F, I, and J), and crystal cells were visualized by anti-Hnt staining (green in G,
(J0), (K0), and (L0). wts mutant lymph glands exhibited differentiation of both
rol lymph glands did not.
tal cells weremarkedwith lz-Gal4-driven expression ofUAS-GFP (green inM
and N0). Crystal cells did not express P1 in control lymph glands (yellow ar-
sed P1 in wts mutant lymph glands (yellow arrowheads in N–N0 0). GFP and
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Figure 2. Warts Regulates Lymph Gland Size and Hemocyte Proliferation
(A–C) DIC images of control w1118 (A) and wts mutant (B) late-third-instar
lymph glands. Lymph gland size is quantified in (C). wts mutant lymph
glands were significantly larger than controls (p < 0.0001; n = 30 for w1118,
n = 16 for wts-Z; error bars represent the SEM).
(D–L) Controlw1118 (D, G, and J) andwtsmutant (E, H, and K) lymph glands at
late second instar (D–E), early third instar (G–H), andmid third instar (J–K).Cells
undergoingDNA replicationwere visualized usingEdU (red inD,E,G,H, J, and
K), and nucleiweremarkedwith DAPI (blue inD, E,G,H, J, andK). The number
of EdU-positive cells per lymph gland is quantified in (F), (I), and (L). In (F), p <
0.0001; n = 13 for (D), n = 11 for (E). In (I), p < 0.001; n = 15 for (G), n = 16 for (H). In
(L), p < 0.001; n = 10 for (J), n = 6 for (K). Error bars represent the SEM.
(M–O) Control w1118 (M) and wts (N) mutant mid-third-instar larval lymph
glands. Mitotic cells were visualized using anti-phospho-Histone H3 (white),
and nuclei were marked with DAPI (blue). The number of cells per lymph
gland positive for phospho-Histone H3 is quantified in (O) (p < 0.001; n =
10 for M, n = 24 for N; error bars represent the SEM).
Scale bars, 20 mm. See also Figure S2.
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2676we observed ectopic induction of Lz in both the primary and
secondary lymph gland lobes (Figures 4A–4A0 0 and S3B–
S3B0 0 0 and data not shown). The ability of Yki to induce Lz
expression in normally Lz2 cells was independent of prolifera-
tion, as Lzwas induced in single cell yki-expressing clones (Fig-
ures S3B–S3B0 0 0). We also observed ectopic expression of Lz in
yki-overexpressing clones anterior to the normal Lz expression
domain in third-instar larval eye-antennal discs (Figures 4B–
4B0 0). This effect was independent of theUAS-yki transgene uti-
lized, as we observed the same result with three independent
transgenes (Figures S3C–S3E0). Furthermore, we observed
ectopic Lz expression in yki-overexpressing clones in larval tis-
sues that do not normally express Lz expression, such as the
brain, wing, and leg discs (Figures S3F and S3G0 and data
not shown). To determine whether Yki regulates Lz at the level
of transcription, we used a transgenic strain that harbored a 1.5
kb fragment of the lz promoter fused to the b-galactosidase
gene [31]. When yki was overexpressed with either en-Gal4 or
ptc-Gal4, we observed elevation of lz-lacZ, showing that Yki
can indeed regulate lz at the level of transcription (Figures
4C–4C0 0 and S3H–S3H0 0).
Scalloped and Yorkie Directly Activate lozenge
Transcription in Kc167 Cells
Our finding that ectopic Yki cell-autonomously induced Lz
expression in vivo prompted us to search for direct evidence
for regulation of lz transcription by Yki and one of its partner
transcription factors, Sd. Sd was found to bind the TEAD/
TEF family DNA binding motif, CATTCCA, in a Sd/Yki-respon-
sive enhancer of diap1 [14]. A similar but more divergent
consensus emerged from genome-wide analysis of Sd binding
[32]. We identified 19 candidate Sd motifs, CATTCY and CAT-
TYC, in the entire lz gene that exhibited some evidence for con-
servation (Figure 4D). Of these, 15 sites were well conserved
based on their preservation to D. pseudoobscura or beyond
(Figure 4D), suggesting that lz is under strong and extensive
evolutionary constraint for regulation by Sd.
We assayed four genomic regions (lz-R1, lz-R2, lz-R3, and
lz-R4) containing multiple conserved Sd binding sites for res-
ponsiveness to ectopic Sd/Yki in reporter assays in Kc167
cells, which display hemocyte properties [33, 34] and express
Lz [18]. When Kc167 cells were cotransfected with Sd and Yki,
we observed upregulation of all four lz reporters but no effect
on reporters bearing regulatory regions from the vestigial and
fringe loci (Figure 4E) [35], neither of which contain Sd sites. All
four lz reporters required Sd binding for activation by Yki, as
mutation of the Sd sites suppressed or ablated luciferase
activity (Figure 4E). These data provide evidence that Sd and
Yki can directly activate lz gene expression via multiple cis-
regulatory regions in the lz locus.
Since these were ectopic tests, we wished to assess
whether endogenous Yki could be detected at the lz locus.
We used chromatin immunoprecipitation (ChIP) to query Yki
occupancy at the lz enhancers in Kc167 cells. We observed
w2-fold enrichment of Yki to the lz-R1b and lz-R2 ChIP ampli-
cons, but not to a control region upstream of lz that lacked a Sd
consensus site (Figure 4F). The conserved sites within the
lz-R1 enhancer are toward the 50 end of this region, but this
region lacks desirable amplicon properties. However, we as-
sayed another amplicon (R1a) and found strong (w10-fold)
enrichment to Yki at this genomic site (Figure 4F). Taken
together, these data support the notion that Yki is endoge-
nously recruited to these Sd sites in hemocytes and that the
Yki/Sd complex activates lz transcription.
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Figure 3. The Hippo Pathway Transcriptional
Regulator Yorkie Influences Crystal Cell
Numbers
(A–C) A controlw1118 lymph gland (A) and a lymph
gland that was hemizygous for ykiB5 (B). Crystal
cells were visualized by expression of UAS-GFP
(green) with the lz-Gal4 driver. The ratio of GFP-
positive crystal cells relative to DAPI-positive
lymph gland cells from multiple animals is quan-
tified in (C). Lymph glands from ykiB5 hemizygous
animals possessed significantly fewer crystal
cells (p = 0.0008; n = 17 for A, n = 12 for B; error
bars represent the SEM).
(D–E0 0 0) Control lymph glands (D–D0 0 0) or lymph
glands expressing the wts RNAi transgene (E–
E0 0 0) under the control of the lz-Gal4driver. Crystal
cells were visualized by coexpression of UAS-
GFP (green in D and E) and staining for Hnt (gray-
scale in D0 and E0 and merged with DIC images).
GFP and protein expression images are merged
with DIC images in (D0 0) and (E0 0). The magnified
images in (D0 0 0) and (E0 0 0) show that lz-Gal4 GFP
and Hnt expression overlap in both genotypes.
(F–I) Control lymph glands (F), lymph glands ex-
pressing the wts RNAi transgene (G), or lymph
glands expressing RNAi transgenes for wts and
yki (H) under the control of the lz-Gal4 driver.
Crystal cells were visualized by expression of
UAS-GFP (green in F–H) andmergedwith DIC im-
ages. GFP-positive crystal cells are quantified in
(I). wts RNAi-expressing lymph glands pos-
sessed significantly more crystal cells than con-
trols (p < 0.001; n = 6 for F, n = 5 for G; error
bars represent the SEM), while wts RNAi, yki
RNAi-expressing lymph glands significantly sup-
pressed this increase (p < 0.0001; n = 5 for G, n =
15 for H; error bars represent the SEM).
Scale bars, 20 mm. See also Figure S2.
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2677The Hippo Pathway Non-Cell-Autonomously Influences
Crystal Cell Numbers in a Notch-Pathway-Dependent
Fashion
When analyzing the effects of Yki overexpression on Lz in
lymph glands, we noted that expression of hyperactive Yki
(Yki3SA) sometimes led to non-cell-autonomous induction of
Lz (data not shown). To investigate this further, we expressed
either Yki3SA or SdGA with hml-Gal4 [1]. Expression of either
transgene induced a significant increase in crystal cell numbers
(Figures S4A–S4D). Upon close examination, crystal cells
almost never overlapped with hml-expressing cells, indicating
that induction of ectopic crystal cells by hyperactive Yki and Sdoccurred in a non-cell-autonomous
fashion (Figures S4E–S4G). A major
determinant of crystal cells is the Notch
pathway [5, 6, 18], which acts during
the third-instar larval period of develop-
ment to promote differentiation of crys-
tal cell progenitors to become mature
crystal cells [17]. Consistent with this, a
substantial increase in cells displaying
Notch activity, observed using a Notch
response element GFP reporter [18],
was observed in hml-SdGA lymph
glands (Figures S4H and S4I0). Further-
more, the ability of hml-driven Yki3SA to
induce ectopic crystal cells was reliant
on full Notch pathway activity, as thisphenotype was suppressed in animals that were heterozygous
for the Notch pathway transcription factor Suppressor of
Hairless [Su(H)] (Figures S4J–S4L). While a mechanistic under-
standing of Notch-Hippo collaboration in the lymph gland
requires further study, it is interesting to note that these path-
ways collaborate to effect numerous development processes
in tissues such as the D. melanogaster ovary and brain
[36, 37] and the murine embryo and liver [38–40].
Conclusions
The Hippo pathway is an important regulator of tissue growth
and cell-fate decisions in epithelial and neural tissues from
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Figure 4. The Hippo Pathway Regulates Expression of the Key Crystal Cell-Fate Determinant, Lozenge
(A–B0 0) A primary third-instar larval lymph gland (A–A0 0) and eye-antennal disc (B–B0 0) harboring clones of tissue expressing UAS-yki transgenes (marked by
GFP in green). Expression of Lz (grayscale in A and B, red in the merged image in B0 0) and Yki (red in A0 0) are shown. Ectopic expression of Lz was induced by
yki overexpression in both lymph glands (indicated by arrowheads in A–A0 0) and eye-antennal discs (indicated by arrowheads in B–B0 0). Asterisks mark
endogenous Lz expression in the lymph gland (A–A0 0) and the posterior region of the eye-antennal disc (B).
(C–C0 0) lz expression, as reported by a 1.5 kb region of the lz promoter fused to the lacZ gene in a wing imaginal disc expressing UAS-yki in the posterior
domain under the control of en-gal4. lz expression is grayscale in the single channel (C) and red in the merged image (C0 0), while UAS-yki expression is
marked by coexpression of UAS-GFP (green in C0 and C0 0).
(legend continued on next page)
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2679both insects and mammals [41]. Here we show that the Hippo
pathway controls the overall size of themajor hematopoietic or-
gan of D. melanogaster, the larval lymph gland, and promotes
the progenitor cell state by repressing Yki activity. While the
antiproliferative activity of theHippopathway in the lymphgland
mirrors its growth-suppressive role in many D. melanogaster
and mammalian tissues, its effects on differentiation do not.
For example, wts loss in the larval eye delays or impairs differ-
entiation of proneural cells [42, 43] and blocks the transition
from neuroepithelium to neuroblasts in the larval brain [36].
In mammals, Runx1, GATA2, and the Notch pathway coop-
erate to regulate differentiation of megakaryocytes [9]. These
same factors also regulate crystal cell fate in D. melanogaster
[1–3]. Given that the Notch and Hippo pathways appear to
collaborate to regulate crystal cell fate and that Yki can induce
expression of the key Runx family transcription factor, Lz, it is
possible that the Hippo pathway also controls mammalian
megakaryocyte differentiation. Further, given the well-docu-
mented role of the Hippo pathway as a tumor-suppressor
pathway in human cancers [41, 44], this study provides ratio-
nale for an investigation of the Hippo pathway in the etiology
of hematopoietic malignancies.
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